Jenkins [49] found that RUNX1 upregulates the expression of type 1 insulin-like growth factor receptor (IGF1R), thereby inhibiting T-ALL cell apoptosis and promoting proliferation. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.